785 related articles for article (PubMed ID: 26527714)
21. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 10: The Cardiac Channelopathies: A Scientific Statement From the American Heart Association and American College of Cardiology.
Ackerman MJ; Zipes DP; Kovacs RJ; Maron BJ
J Am Coll Cardiol; 2015 Dec; 66(21):2424-2428. PubMed ID: 26542662
[No Abstract] [Full Text] [Related]
22. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 5: Valvular Heart Disease: A Scientific Statement From the American Heart Association and American College of Cardiology.
Bonow RO; Nishimura RA; Thompson PD; Udelson JE
J Am Coll Cardiol; 2015 Dec; 66(21):2385-2392. PubMed ID: 26542667
[No Abstract] [Full Text] [Related]
23. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 6: Hypertension: A Scientific Statement from the American Heart Association and the American College of Cardiology.
Black HR; Sica D; Ferdinand K; White WB
J Am Coll Cardiol; 2015 Dec; 66(21):2393-2397. PubMed ID: 26542658
[No Abstract] [Full Text] [Related]
24. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 13: Commotio Cordis: A Scientific Statement From the American Heart Association and American College of Cardiology.
Link MS; Estes NAM; Maron BJ
J Am Coll Cardiol; 2015 Dec; 66(21):2439-2443. PubMed ID: 26542669
[No Abstract] [Full Text] [Related]
25. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Preamble, Principles, and General Considerations: A Scientific Statement From the American Heart Association and American College of Cardiology.
Maron BJ; Zipes DP; Kovacs RJ
J Am Coll Cardiol; 2015 Dec; 66(21):2343-2349. PubMed ID: 26542655
[No Abstract] [Full Text] [Related]
26. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 11: Drugs and Performance-Enhancing Substances: A Scientific Statement From the American Heart Association and American College of Cardiology.
Estes NAM; Kovacs RJ; Baggish AL; Myerburg RJ
J Am Coll Cardiol; 2015 Dec; 66(21):2429-2433. PubMed ID: 26542661
[No Abstract] [Full Text] [Related]
27. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 1: Classification of Sports: Dynamic, Static, and Impact: A Scientific Statement From the American Heart Association and American College of Cardiology.
Levine BD; Baggish AL; Kovacs RJ; Link MS; Maron MS; Mitchell JH
J Am Coll Cardiol; 2015 Dec; 66(21):2350-2355. PubMed ID: 26542656
[No Abstract] [Full Text] [Related]
28. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 9: Arrhythmias and Conduction Defects: A Scientific Statement From the American Heart Association and American College of Cardiology.
Zipes DP; Link MS; Ackerman MJ; Kovacs RJ; Myerburg RJ; Estes NAM
J Am Coll Cardiol; 2015 Dec; 66(21):2412-2423. PubMed ID: 26542670
[No Abstract] [Full Text] [Related]
29. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 4: Congenital Heart Disease: A Scientific Statement From the American Heart Association and American College of Cardiology.
Van Hare GF; Ackerman MJ; Evangelista JK; Kovacs RJ; Myerburg RJ; Shafer KM; Warnes CA; Washington RL
J Am Coll Cardiol; 2015 Dec; 66(21):2372-2384. PubMed ID: 26542660
[No Abstract] [Full Text] [Related]
30. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology.
Maron BJ; Udelson JE; Bonow RO; Nishimura RA; Ackerman MJ; Estes NAM; Cooper LT; Link MS; Maron MS
J Am Coll Cardiol; 2015 Dec; 66(21):2362-2371. PubMed ID: 26542657
[No Abstract] [Full Text] [Related]
31. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 12: Emergency Action Plans, Resuscitation, Cardiopulmonary Resuscitation, and Automated External Defibrillators: A Scientific Statement From the American Heart Association and American College of Cardiology.
Link MS; Myerburg RJ; Estes NAM
J Am Coll Cardiol; 2015 Dec; 66(21):2434-2438. PubMed ID: 26542665
[No Abstract] [Full Text] [Related]
32. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 7: Aortic Diseases, Including Marfan Syndrome: A Scientific Statement From the American Heart Association and American College of Cardiology.
Braverman AC; Harris KM; Kovacs RJ; Maron BJ
J Am Coll Cardiol; 2015 Dec; 66(21):2398-2405. PubMed ID: 26542664
[No Abstract] [Full Text] [Related]
33. Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation.
Maron BJ; Thompson PD; Ackerman MJ; Balady G; Berger S; Cohen D; Dimeff R; Douglas PS; Glover DW; Hutter AM; Krauss MD; Maron MS; Mitten MJ; Roberts WO; Puffer JC;
Circulation; 2007 Mar; 115(12):1643-455. PubMed ID: 17353433
[No Abstract] [Full Text] [Related]
34. Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines.
; ; ; ; Wann LS; Curtis AB; Ellenbogen KA; Estes NA; Ezekowitz MD; Jackman WM; January CT; Lowe JE; Page RL; Slotwiner DJ; Stevenson WG; Tracy CM; Fuster V; Rydén LE; Cannom DS; Crijns HJ; Curtis AB; Ellenbogen KA; Halperin JL; Le Heuzey J; Kay GN; Lowe JE; Olsson SB; Prystowsky EN; Tamargo JL; Wann LS
Circulation; 2013 May; 127(18):1916-26. PubMed ID: 23545139
[No Abstract] [Full Text] [Related]
35. The evolution and future of ACC/AHA clinical practice guidelines: a 30-year journey: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
Jacobs AK; Anderson JL; Halperin JL
J Am Coll Cardiol; 2014 Sep; 64(13):1373-84. PubMed ID: 25103073
[No Abstract] [Full Text] [Related]
36. 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. [corrected].
Tracy CM; Epstein AE; Darbar D; DiMarco JP; Dunbar SB; Estes NA; Ferguson TB; Hammill SC; Karasik PE; Link MS; Marine JE; Schoenfeld MH; Shanker AJ; Silka MJ; Stevenson LW; Stevenson WG; Varosy PD; Ellenbogen KA; Freedman RA; Gettes LS; Gillinov AM; Gregoratos G; Hayes DL; Page RL; Stevenson LW; Sweeney MO; ; ;
Circulation; 2012 Oct; 126(14):1784-800. PubMed ID: 22965336
[No Abstract] [Full Text] [Related]
37. ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines.
Anderson JL; Heidenreich PA; Barnett PG; Creager MA; Fonarow GC; Gibbons RJ; Halperin JL; Hlatky MA; Jacobs AK; Mark DB; Masoudi FA; Peterson ED; Shaw LJ
J Am Coll Cardiol; 2014 Jun; 63(21):2304-22. PubMed ID: 24681044
[No Abstract] [Full Text] [Related]
38. Preparticipation Cardiovascular Screening--Finding the Middle Ground.
Roberts WO
Curr Sports Med Rep; 2016; 15(2):61-3. PubMed ID: 26963006
[No Abstract] [Full Text] [Related]
39. ACCF/AHA methodology for the development of quality measures for cardiovascular technology: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures.
Bonow RO; Douglas PS; Buxton AE; Cohen DJ; Curtis JP; Delong E; Drozda JP; Ferguson TB; Heidenreich PA; Hendel RC; Masoudi FA; Peterson ED; Taylor AJ
J Am Coll Cardiol; 2011 Sep; 58(14):1517-38. PubMed ID: 21880456
[TBL] [Abstract][Full Text] [Related]
40. Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
Anderson JL; Halperin JL; Albert NM; Bozkurt B; Brindis RG; Curtis LH; DeMets D; Guyton RA; Hochman JS; Kovacs RJ; Ohman EM; Pressler SJ; Sellke FW; Shen WK
Circulation; 2013 Apr; 127(13):1425-43. PubMed ID: 23457117
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
